VolitionRx Limited Current Assets
VolitionRx Limited (VNRX) had Current Assets of $4.09 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-13
- 2026-06-30: Assets, Current $4.09M.
- 2026-03-31: Assets, Current $4.52M.
- 2025-12-31: Assets, Current $2.06M.
- 2025-09-30: Assets, Current $1.33M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $4.09M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $4.52M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $2.06M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $1.33M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $3.26M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $3.29M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $4.06M 10-K · filed 2026-03-31 |
| 2024-09-30 | $6.80M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $7.35M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $13.47M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $21.85M 10-K · filed 2025-03-31 |
| 2023-09-30 | $12.20M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $21.51M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $11.96M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $12.17M 10-K · filed 2024-03-25 |
| 2022-09-30 | $17.67M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $18.65M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $25.96M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $21.98M 10-K · filed 2023-03-15 |
| 2021-09-30 | $24.42M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $29.39M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $34.67M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $20.33M 10-K · filed 2022-03-30 |
| 2020-09-30 | $22.16M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $22.42M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $13.10M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $17.56M 10-K · filed 2021-03-22 |
| 2019-09-30 | $20.31M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $19.24M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $17.07M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $13.90M 10-K · filed 2020-02-20 |
| 2018-09-30 | $17.06M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $12.52M 10-Q · filed 2018-08-13 |
| 2018-03-31 | $14.91M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $10.57M 10-K · filed 2019-03-13 |
| 2017-09-30 | $14.26M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $16.95M 10-Q · filed 2017-08-10 |
| 2017-03-31 | $18.99M 10-Q · filed 2017-05-11 |
| 2016-12-31 | $22.01M 10-K · filed 2018-03-01 |
| 2016-09-30 | $12.91M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $14.93M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $17.43M 10-Q · filed 2016-05-13 |
| 2015-12-31 | $6.22M 10-K · filed 2017-03-10 |
| 2015-09-30 | $7.26M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $9.69M 10-Q · filed 2015-08-11 |
| 2015-03-31 | $11.33M 10-Q · filed 2015-05-12 |
| 2014-12-31 | $2.34M 10-K · filed 2016-03-11 |
| 2014-09-30 | $2.67M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $2.01M 10-Q · filed 2014-08-01 |
| 2014-03-31 | $2.91M 10-Q · filed 2014-05-15 |
| 2013-12-31 | $1.01M 10-K · filed 2015-03-18 |
| 2013-09-30 | $816.74K 10-Q · filed 2013-10-31 |
| 2013-06-30 | $1.06M 10-Q · filed 2013-07-29 |
| 2013-03-31 | $797.91K 10-Q · filed 2013-05-06 |
| 2012-12-31 | $695.14K 10-K · filed 2014-03-28 |
| 2012-09-30 | $709.46K 10-Q · filed 2012-11-14 |
| 2012-06-30 | $719.64K 10-Q · filed 2012-08-14 |
| 2012-03-31 | $604.39K 10-Q · filed 2012-05-15 |
| 2011-12-31 | $699.47K 10-K · filed 2013-04-01 |
| 2010-12-31 | $65.15K 10-KT/A · filed 2012-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |